menu search

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
– 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate. – Two-year local recurrence-free survival rate of 77%. – The analysis also showed no grade 3 or higher acute treatment-related toxicities, with approx. 20% of patients experiencing acute grade 2 toxicities. – No grade 2 […] The post Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT appeared first on ForexTV... Read More
Posted: Aug 17 2023, 21:00
Author Name: forextv
Views: 101953

Search within

Pages Search Results: